CARE for Blood Cancer Act of 2026

(a) In general. The Secretary shall award grants to eligible entities to conduct research on best practices for awareness and education with respect to blood cancer, including—

(1) behavioral studies, survivorship studies, and other research on the impact of blood cancer diagnosis;

(2) formative research to assist with the development of educational messages and information for the public, targeted populations, and their families about the social, environmental, and occupational risk factors for developing blood cancer;

(3) testing and evaluating existing and new social marketing strategies to raise awareness of blood cancer, including common warning signs and diagnostic tests;

(4) reducing disparities in blood cancer incidence, diagnostic delays, access to treatment, morbidity, and mortality, including in populations with higher than average rates; and

(5) surveys of health care providers and the public regarding knowledge, attitudes, and practices related to blood cancer prevention and control in high-risk populations.

(b) Eligibility. To be eligible for a grant under this section, an entity shall be—

(1) a State, local, territorial, or Tribal health agency or organization;

(2) a qualified nongovernmental entity, as determined by the Secretary; or

(3) a consortium of entities that includes an entity described in paragraph (1).

(c) Priority for high-Risk communities and areas. In awarding grants under this section, the Secretary shall give priority to any eligible entity whose application—

(1) is made with respect to a community with a high risk of blood cancers; or

(2) is made with respect to a geographic area in which there is—

(A) a substantial rate of mortality from blood cancer; or

(B) a substantial incidence of blood cancer.